View Older Stories

Mar 3, 2026 12:49PM Scholar Rock (SRRK) PT Raised to $70 at BMO Capital

Mar 3, 2026 07:02AM Scholar Rock Holding Corp. (SRRK) Tops Q4 EPS by 2c

Jan 26, 2026 06:47AM Scholar Rock (SRRK) PT Raised to $58 at H.C. Wainwright

Jan 12, 2026 07:05AM Scholar Rock targets 2026 apitegromab BLA resubmission and launch

Jan 9, 2026 05:01AM Citi Starts Scholar Rock (SRRK) at Buy

Jan 7, 2026 01:02AM UBS Starts Scholar Rock (SRRK) at Buy

Dec 11, 2025 07:18AM Scholar Rock's (SRRK) Apitegromab Approval Certain - Cantor Fitzgerald

Nov 17, 2025 04:15PM Wolfe Research Starts Scholar Rock (SRRK) at Outperform

Nov 17, 2025 08:13AM Scholar Rock (SRRK) PT Raised to $50 at BMO Capital

Nov 14, 2025 07:03AM Scholar Rock Holding Corp. (SRRK) Misses Q3 EPS by 6c

Oct 20, 2025 08:30AM Scholar Rock (SRRK) PT Lowered to $44 at Truist Securities

Oct 14, 2025 07:29AM Truist Securities Reiterates Buy Rating on Scholar Rock (SRRK)

Oct 13, 2025 11:16AM Scholar Rock stock falls after FDA flags issues at manufacturing facility

Oct 9, 2025 06:11AM BofA Securities Starts Scholar Rock (SRRK) at Buy

Sep 24, 2025 08:59AM Truist on Scholar Rock (SRRK): 'We See Today's Stock Weakness as a Buying Opportunity'

Sep 24, 2025 08:39AM Scholar Rock (SRRK) PT Lowered to $51 at Piper Sandler

Sep 24, 2025 06:39AM Scholar Rock (SRRK) PT Lowered to $44 at H.C. Wainwright

Sep 24, 2025 04:15AM Scholar Rock (SRRK) PT Lowered to $48 at Leerink Partners

Sep 23, 2025 04:08PM Scholar Rock (SRRK) PT Lowered to $44 at Barclays

Sep 23, 2025 07:00AM FDA rejects Scholar Rock's apitegromab application due to facility issues

Sep 23, 2025 06:59AM Scholar Rock Holding Corp. (SRRK) Halted, News Pending

Sep 17, 2025 04:36AM Barclays Starts Scholar Rock (SRRK) at Overweight

Sep 15, 2025 06:02AM Leerink Partners Starts Scholar Rock (SRRK) at Outperform

Aug 21, 2025 03:06AM Jefferies Assumes Scholar Rock (SRRK) at Buy

Aug 15, 2025 06:37AM Raymond James Adjusts Analysts Current Favorites List

Aug 7, 2025 07:53AM Scholar Rock (SRRK) PT Lowered to $45 at BMO Capital

Aug 6, 2025 12:59PM Raymond James Reiterates Strong Buy Rating on Scholar Rock (SRRK)

Aug 6, 2025 07:03AM Scholar Rock Holding Corp. (SRRK) Misses Q2 EPS by 32c

Jul 29, 2025 04:28PM Raymond James Assumes Scholar Rock (SRRK) at Strong Buy

Jul 17, 2025 06:16AM Cantor Fitzgerald Starts Scholar Rock (SRRK) at Overweight

Jun 26, 2025 07:55AM Truist Securities Reiterates Buy Rating on Scholar Rock (SRRK)

Jun 20, 2025 06:38AM H.C. Wainwright Reiterates Buy Rating on Scholar Rock (SRRK)

Jun 18, 2025 07:00AM Scholar Rock Holding (SRRK) Reports Positive Phase 2 EMBRAZE Trial Results Demonstrating Statistically Significant Preservation of Lean Mass with Apitegromab During Tirzepatide-Induced Weight Loss

Jun 13, 2025 11:43AM Jefferies: 'We highlight multiple de-risked or commercial-stage names that we think have promising M&A potential'

Jun 2, 2025 08:05AM Scholar Rock Holding Corp. (SRRK) Appoints as Rebecca McLeod Chief Brand Officer and U.S. General Manager

May 14, 2025 07:02AM Scholar Rock Holding Corp. (SRRK) Misses Q1 EPS by 1c

Apr 28, 2025 11:23AM Truist Securities Reiterates Buy Rating on Scholar Rock (SRRK)

Apr 28, 2025 07:03AM Scholar Rock Holding Corp. (SRRK) Appoints David L. Hallal as CEO

Apr 23, 2025 08:21AM Piper Sandler: 'Scholar Rock (SRRK) Shares are Significantly Undervalued'

Mar 26, 2025 09:45AM Truist Weighs In on Obesity: 'Catalyst-Rich 2025 Ahead in a Growing Competitive Landscape'

Mar 25, 2025 09:42AM Truist Securities Reiterates Buy Rating on Scholar Rock (SRRK)

Mar 25, 2025 07:31AM Scholar Rock Holding Corp. (SRRK): FDA Grants Priority Review for BLA and EMA Accepts MAA for Apitegromab as a Treatment for SMA

Mar 14, 2025 04:22PM Scholar Rock Holding Corp. (SRRK) announces employee inducement grants

Mar 6, 2025 03:09PM Scholar Rock Holding Corp. (SRRK) spreader of 1K contracts of April 45 and 60 calls

Feb 27, 2025 07:08AM Scholar Rock Holding Corp. (SRRK) Misses Q4 EPS by 189c

Feb 25, 2025 08:15AM Truist Reiterates Buy Rating on Scholar Rock (SRRK) Ahead of EMBRAZE Data

Jan 29, 2025 08:05AM Scholar Rock Holding Corp. (SRRK) Submits BLA to the U.S. FDA for Apitegromab as a Treatment for Patients with SMA

Jan 8, 2025 04:00PM Scholar Rock Holding Corp. (SRRK) Highlights 2025 Strategic Priorities

Jan 2, 2025 12:51PM Biopharma 2025 Preview: 'Piper Sandler Sees Lots of Upside Opportunity'

Nov 26, 2024 06:58AM Scholar Rock (SRRK) PT Raised to $50 at H.C. Wainwright

View Older Stories